Sclerosis, Progressive Systemic Completed Phase 3 Trials for Bosentan (DB00559)

Also known as: Systemic Sclerosis / Sclerosis, Systemic / Progressive systemic sclerosis / Scleroderma, Systemic / Scleroderma

IndicationStatusPhase
DBCOND0080156 (Sclerosis, Progressive Systemic)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00319696Bosentan in Digital UlcersTreatment
NCT00077584Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With SclerodermaTreatment